Health Canada20 Apr 2026
SUVEXX: The assay is out of specification in the affected lot.
Health Canada published a recall notice for SUVEXX: The assay is out of specification in the affected lot on 20 Apr 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 20 Apr 2026
- Recall type
- Health product recall
- Companies
- ARALEZ PHARMACEUTICALS CANADA INC · 6733 Mississauga Rd, Suite 800 · Mississauga, ON · L5N 6J5
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The assay is out of specification in the affected lot. What you should do What to do: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Product Name Market Authorization Dosage Form Strength Lot number SUVEXX DIN 02496305 Tablet Sumatriptan 85mg Naproxen sodium 500mg 0000159323 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.